R I Nicholson|J M Gee|M E Harper - JoVE Visualize

Showing results (41-50 of 304) with videos related to

Pageof 31

Sort By:

Oncogene|October 27, 1998

c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancerJ M Knowlden, J M Gee, L T Seery, et al.

International Journal of Cancer|October 31, 2000

Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expressionS S Yip, A J Crew, J M Gee, et al.

British Journal of Cancer|March 1, 1979

Effects of high doses of a series of new luteinizing hormone-releasing hormone analogues in intact female ratsP V Maynard, R I Nicholson

European Journal of Cancer (Oxford, England : 1990)|January 1, 1993

Isolation of pMGT1: a gene that is repressed by oestrogen and increased by antioestrogens and antiprogestinsD L Manning, R I Nicholson

Journal of Steroid Biochemistry|October 1, 1989

Gn-RH agonists in breast and gynaecologic cancer treatmentR I Nicholson, K J Walker

Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1985

Influence of LH-RH agonists on the growth and hormonal environment of breast and prostate cancerR I Nicholson, K J Walker

British Journal of Cancer|March 1, 1979

Anti-tumour activity of ICI 118630, a new potent luteinizing hormone-releasing hormone agonistR I Nicholson, P V Maynard

Annals of the New York Academy of Sciences|July 4, 2002

Modulation of epidermal growth factor receptor in endocrine-resistant, estrogen-receptor-positive breast cancerR I Nicholson, I R Hutcheson, M E Harper, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998

Use of reverse transcription-polymerase chain reaction methodology to detect estrogen-regulated gene expression in small breast cancer specimensJ M Knowlden, J M Gee, S Bryant, et al.

International Journal of Cancer|December 1, 1994

Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapyJ M Gee, J F Robertson, I O Ellis, et al.

Pageof 31

Showing results (41-50 of 304) with videos related to

Sort By:

Pageof 31

Oncogene|October 27, 1998

c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancerJ M Knowlden, J M Gee, L T Seery, et al.

International Journal of Cancer|October 31, 2000

Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expressionS S Yip, A J Crew, J M Gee, et al.

British Journal of Cancer|March 1, 1979

Effects of high doses of a series of new luteinizing hormone-releasing hormone analogues in intact female ratsP V Maynard, R I Nicholson

European Journal of Cancer (Oxford, England : 1990)|January 1, 1993

Isolation of pMGT1: a gene that is repressed by oestrogen and increased by antioestrogens and antiprogestinsD L Manning, R I Nicholson

Journal of Steroid Biochemistry|October 1, 1989

Gn-RH agonists in breast and gynaecologic cancer treatmentR I Nicholson, K J Walker

Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1985

Influence of LH-RH agonists on the growth and hormonal environment of breast and prostate cancerR I Nicholson, K J Walker

British Journal of Cancer|March 1, 1979

Anti-tumour activity of ICI 118630, a new potent luteinizing hormone-releasing hormone agonistR I Nicholson, P V Maynard

Annals of the New York Academy of Sciences|July 4, 2002

Modulation of epidermal growth factor receptor in endocrine-resistant, estrogen-receptor-positive breast cancerR I Nicholson, I R Hutcheson, M E Harper, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998

Use of reverse transcription-polymerase chain reaction methodology to detect estrogen-regulated gene expression in small breast cancer specimensJ M Knowlden, J M Gee, S Bryant, et al.

International Journal of Cancer|December 1, 1994

Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapyJ M Gee, J F Robertson, I O Ellis, et al.

Pageof 31